Imaging MS part 3
Imaging MS part 3
批准号:
456074189
负责人:
金额:
$0.0万
依托单位国家:
德国
项目类别:
Major Research Instrumentation
财政年份:
2021
资助国家:
德国
项目状态:
未结题
起止时间:
2020-12-31 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
With the opening of a second site at the TUM campus at the University hospital Klinikum rechts der Isar (in the following referred to as BayBioMS@MRI) the Technical University Munich (TUM) strengthens the Bavarian Center for Biomolecular Mass Spectrometry (BayBioMS) as central instrument platform for mass spectrometry in life science research. This expansion has become necessary due to the increased demand for mass spectrometry technology applications in cutting-edge international research. By building on synergies between different research departments we provide improved access to key research techniques for all scientists at TUM.Personnel and rooms for the BayBioMS@MRI have already been provided by the TUM. The aim of the current application is now to realize the BayBaMS@MRI major equipment infrastructure. In detail, the TUM intends to acquire two high resolution mass spectrometers with different measurement technique capabilities for proteomic research and one high resolution mass spectrometer for mass spectrometry based imaging applications. The proteomic mass spectrometers are coupled with nano-HPLC systems and a mobile MALDI imaging source. The combined application also contains an automated sample preparation system consisting of an off-line HPLC and a liquid handling platform as well as the necessary IT infrastructure for data storage, processing and analysis. Together these components form a functional unit and this concept has been used very successfully at the BayBioMS location in Freising for many years.The application is based on concrete research projects from 18 research groups. These projects are an example for the multitude of future projects that will be supported through this new infrastructure investment. Main goals of the BayBioMS@MRI are: 1. To offer access to state-of-the-art LC-MS and Imaging MS equipment in order to support cutting-edge research on the highest international level.2. To obtain high quality results by providing scientific and technical know-how, start-to-end projects support and the best possible advice for our users and collaboration partners. 3. To promote the education and scientific expertise of students, scientists and technical staff by giving seminars, workshops and courses for this modern key technology.4. To pursue our own innovative research projects in order to advance technical aspects like automation, sample preparation, measurement techniques or data analysis.5. And to foster the connection between the existing organization structure and scientific expertise at the BayBioMS at the TUM campus in Freising and the new site at the TUM clinic campus in Munich in order to take full advantage of all existing and planned resources and generate synergies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
KW6002通过调控IFN-γ炎症通路及类淋巴功能改善MS-ON病理的机制研究
-
批准号:JCZRQNB202600561
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于UPLC-QTOF-MS技术的白花泡桐叶化学成分分析及质量评价研究
-
批准号:2026JJ80718
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:黄莉
-
依托单位:
基于CMC/UPLC-Q-TOF/MS的复骨健步丸活性成分筛选及其活性验证
-
批准号:2026JJ82588
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张年
-
依托单位:
肠道代谢物RKH通过Ms4a4a抑制巨噬细胞极化改善肺纤维化的机制研究
-
批准号:2026JJ50307
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:彭红
-
依托单位:
一体化微流控芯片与ICP-MS在线联用技术用于循环肿瘤细胞的分析研究
-
批准号:JCZRMS202600912
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于UPLC-MS/MS构建化妆品中28种荧光增白剂高通量快速检测方法的研究
-
批准号:2026JJ80991
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:潘小红
-
依托单位:
基于 UPLC-Q-TOF-MS/MS 分析的 异功散活性成分评价及提取工艺研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:魏江平
-
依托单位:
iPSC 来源 CAR-Ms 调控血管表型重塑促进创面无瘢痕再生的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:曾文
-
依托单位:
基于UPLC-MS/MS技术的含片姜黄中药制剂的补充检验方法示范性研究-以人参再造丸为例
-
批准号:2025JJ80195
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:占丽琴
-
依托单位:
Dysosmobacter welbionis 菌通过调控“miR-743a-3p/MS4A6D/ MAPK”轴介导巨噬细胞 M2 极化缓解肠源性脓毒症损伤的机制研究
-
批准号:2025JJ70531
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:刘浩波
-
依托单位: